Literature DB >> 28193630

Mycolates of Mycobacterium tuberculosis modulate the flow of cholesterol for bacillary proliferation in murine macrophages.

Ilke Vermeulen1, Mark Baird2, Juma Al-Dulayymi2, Muriel Smet3, Jan Verschoor4, Johan Grooten5.   

Abstract

The differentiation of macrophages into lipid-filled foam cells is a hallmark of the lung granuloma that forms in patients with active tuberculosis (TB). Mycolic acids (MAs), the abundant lipid virulence factors in the cell wall of Mycobacterium tuberculosis (Mtb), can induce this foam phenotype possibly as a way to perturb host cell lipid homeostasis to support the infection. It is not exactly clear how MAs allow differentiation of foam cells during Mtb infection. Here we investigated how chemically synthetic MAs, each with a defined stereochemistry similar to natural Mtb-associated mycolates, influence cell foamy phenotype and mycobacterial proliferation in murine host macrophages. Using light and laser-scanning-confocal microscopy, we assessed the influence of MA structure first on the induction of granuloma cell types, second on intracellular cholesterol accumulation, and finally on mycobacterial growth. While methoxy-MAs (mMAs) effected multi-vacuolar giant cell formation, keto-MAs (kMAs) induced abundant intracellular lipid droplets that were packed with esterified cholesterol. Macrophages from mice treated with kMA were permissive to mycobacterial growth, whereas cells from mMA treatment were not. This suggests a separate yet key involvement of oxygenated MAs in manipulating host cell lipid homeostasis to establish the state of TB.
Copyright © 2017 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  confocal microscopy; foam cell; infection; lipid droplets; liver X receptor; mycolic acid; tuberculosis

Mesh:

Substances:

Year:  2017        PMID: 28193630      PMCID: PMC5392746          DOI: 10.1194/jlr.M073171

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  59 in total

1.  SnapShot: Lipid Droplets.

Authors:  Natalie Krahmer; Yi Guo; Robert V Farese; Tobias C Walther
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

2.  Standardization of natural mycolic acid antigen composition and production for use in biomarker antibody detection to diagnose active tuberculosis.

Authors:  F L Ndlandla; V Ejoh; A C Stoltz; B Naicker; A D Cromarty; S van Wyngaardt; M Khati; L S Rotherham; Y Lemmer; J Niebuhr; C R Baumeister; J R Al Dulayymi; H Swai; M S Baird; J A Verschoor
Journal:  J Immunol Methods       Date:  2016-05-28       Impact factor: 2.303

Review 3.  PI3K and cancer: lessons, challenges and opportunities.

Authors:  David A Fruman; Christian Rommel
Journal:  Nat Rev Drug Discov       Date:  2014-02       Impact factor: 84.694

4.  Direct visualization by cryo-EM of the mycobacterial capsular layer: a labile structure containing ESX-1-secreted proteins.

Authors:  Musa Sani; Edith N G Houben; Jeroen Geurtsen; Jason Pierson; Karin de Punder; Maaike van Zon; Brigitte Wever; Sander R Piersma; Connie R Jiménez; Mamadou Daffé; Ben J Appelmelk; Wilbert Bitter; Nicole van der Wel; Peter J Peters
Journal:  PLoS Pathog       Date:  2010-03-05       Impact factor: 6.823

5.  The role of the granuloma in expansion and dissemination of early tuberculous infection.

Authors:  J Muse Davis; Lalita Ramakrishnan
Journal:  Cell       Date:  2009-01-09       Impact factor: 41.582

6.  Location of functional groups in mycobacterial meromycolate chains; the recognition of new structural principles in mycolic acids.

Authors:  Motoko Watanabe; Yutaka Aoyagi; Hidemichi Mitome; Tsuyoshi Fujita; Hideo Naoki; Malin Ridell; David E Minnikin
Journal:  Microbiology       Date:  2002-06       Impact factor: 2.777

7.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

8.  The changes in mycolic acid structures caused by hadC mutation have a dramatic effect on the virulence of Mycobacterium tuberculosis.

Authors:  Nawel Slama; Stevie Jamet; Wafa Frigui; Alexandre Pawlik; Daria Bottai; Françoise Laval; Patricia Constant; Anne Lemassu; Kaymeuang Cam; Mamadou Daffé; Roland Brosch; Nathalie Eynard; Annaïk Quémard
Journal:  Mol Microbiol       Date:  2015-11-27       Impact factor: 3.501

9.  A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen.

Authors:  Chirajyoti Deb; Chang-Muk Lee; Vinod S Dubey; Jaiyanth Daniel; Bassam Abomoelak; Tatiana D Sirakova; Santosh Pawar; Linda Rogers; Pappachan E Kolattukudy
Journal:  PLoS One       Date:  2009-06-29       Impact factor: 3.240

10.  Targeting multiple response regulators of Mycobacterium tuberculosis augments the host immune response to infection.

Authors:  Srijon Kaushik Banerjee; Manish Kumar; Reshma Alokam; Arun Kumar Sharma; Ayan Chatterjee; Ranjeet Kumar; Sanjaya Kumar Sahu; Kuladip Jana; Ramandeep Singh; Perumal Yogeeswari; Dharmarajan Sriram; Joyoti Basu; Manikuntala Kundu
Journal:  Sci Rep       Date:  2016-05-16       Impact factor: 4.379

View more
  6 in total

1.  The antigenicity and cholesteroid nature of mycolic acids determined by recombinant chicken antibodies.

Authors:  Heena Ranchod; Fortunate Ndlandla; Yolandy Lemmer; Mervyn Beukes; Johann Niebuhr; Juma Al-Dulayymi; Susan Wemmer; Jeanni Fehrsen; Mark Baird; Jan Verschoor
Journal:  PLoS One       Date:  2018-08-09       Impact factor: 3.240

2.  A Two-Way Proteome Microarray Strategy to Identify Novel Mycobacterium tuberculosis-Human Interactors.

Authors:  Tingming Cao; Lingna Lyu; Hongyan Jia; Jinghui Wang; Fengjiao Du; Liping Pan; Zihui Li; Aiying Xing; Jing Xiao; Yu Ma; Zongde Zhang
Journal:  Front Cell Infect Microbiol       Date:  2019-03-28       Impact factor: 5.293

3.  Revealing solvent-dependent folding behavior of mycolic acids from Mycobacterium tuberculosis by advanced simulation analysis.

Authors:  Wilma Groenewald; Ricardo A Parra-Cruz; Christof M Jäger; Anna K Croft
Journal:  J Mol Model       Date:  2019-02-14       Impact factor: 1.810

4.  Analyzing the impact of Mycobacterium tuberculosis infection on primary human macrophages by combined exploratory and targeted metabolomics.

Authors:  Frank Vrieling; Sarantos Kostidis; Herman P Spaink; Mariëlle C Haks; Oleg A Mayboroda; Tom H M Ottenhoff; Simone A Joosten
Journal:  Sci Rep       Date:  2020-04-27       Impact factor: 4.379

Review 5.  Advances in Cardiovascular Disease Lipid Research Can Provide Novel Insights Into Mycobacterial Pathogenesis.

Authors:  Shyamala Thirunavukkarasu; Shabaana A Khader
Journal:  Front Cell Infect Microbiol       Date:  2019-04-18       Impact factor: 5.293

6.  Long-term live-cell lipid droplet-targeted biosensor development for nanoscopic tracking of lipid droplet-mitochondria contact sites.

Authors:  Chengying Zhang; Huarong Shao; Jie Zhang; Xinyan Guo; Yue Liu; Zhigang Song; Fei Liu; Peixue Ling; Longguang Tang; Kang-Nan Wang; Qixin Chen
Journal:  Theranostics       Date:  2021-06-22       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.